BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36856023)

  • 1. A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa.
    Anderson WJ; Dong F; Fletcher CDM; Hirsch MS; Nucci MR
    Am J Surg Pathol; 2023 May; 47(5):535-546. PubMed ID: 36856023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
    Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
    Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
    Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
    Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
    Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions.
    Bennett JA; Ordulu Z; Pinto A; Wanjari P; Antonescu CR; Ritterhouse LL; Oliva E
    Mod Pathol; 2022 Apr; 35(4):515-523. PubMed ID: 34131293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.
    Folpe AL; Mentzel T; Lehr HA; Fisher C; Balzer BL; Weiss SW
    Am J Surg Pathol; 2005 Dec; 29(12):1558-75. PubMed ID: 16327428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.
    Vang R; Kempson RL
    Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters.
    Doyle LA; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2013 Dec; 37(12):1769-82. PubMed ID: 24061520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
    Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
    Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification.
    Wang XT; Fang R; Zhang RS; Ye SB; Li R; Wang X; Pan R; Liu C; Chen JY; Zhao M; Teng XD; Yu WJ; Li YJ; Wang FH; Zhang JG; Yang QC; Zhang YS; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
    J Pathol; 2020 Aug; 251(4):365-377. PubMed ID: 32418203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.
    Maloney N; Giannikou K; Lefferts J; Bridge JA; Linos K
    Hum Pathol; 2018 Dec; 82():125-130. PubMed ID: 29626599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEComa: morphology and genetics of a complex tumor family.
    Thway K; Fisher C
    Ann Diagn Pathol; 2015 Oct; 19(5):359-68. PubMed ID: 26144278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm With Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations.
    Papke DJ; Dickson BC; Sholl L; Fletcher CDM
    Am J Surg Pathol; 2022 Jan; 46(1):33-43. PubMed ID: 34081037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):493-501. PubMed ID: 18223480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus.
    Cao B; Huang Y
    BMC Womens Health; 2022 Dec; 22(1):523. PubMed ID: 36522714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft Tissue Perivascular Epithelioid Cell Tumors.
    Hammer PM; Tan SY
    Surg Pathol Clin; 2024 Mar; 17(1):105-118. PubMed ID: 38278600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
    Chiang S; Vasudevaraja V; Serrano J; Stewart CJR; Oliva E; Momeni-Boroujeni A; Jungbluth AA; Da Cruz Paula A; da Silva EM; Weigelt B; Park KJ; Soslow RA; Murali R; Ellenson LH; Benayed R; Ladanyi M; Abu-Rustum NR; Dickson MA; Cohen S; Aghajanian C; Hensley ML; Lee CH; Snuderl M; Konner JA
    Mod Pathol; 2022 Jan; 35(1):117-127. PubMed ID: 34561551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
    Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
    Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.